ArticleWorld journal of gastrointestinal oncology2024

Temozolomide and capecitabine regimen as first-line treatment in advanced gastroenteropancreatic neuroendocrine tumors at a Latin American reference center.

Wagner Eduardo Cruz-Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.